Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 16
Phase 21

Trial Status

Recruiting5
Other2

Role Distribution

Principal Investigator6
Other Roles1
PI Rate86%

Activity Timeline

Clinical Trials (7)

NCT06946199Phase 1Recruiting
An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
PrincipalinvestigatorStart date: 2025-06-23
NCT06245746Phase 1Recruiting
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Acute Myeloid LeukemiaAnemiaBleeding+3 more
PrincipalinvestigatorStart date: 2025-02-26
NCT06349343Phase 1Recruiting
CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
PrincipalinvestigatorStart date: 2025-02-10
NCT06400537Phase 1Recruiting
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
PrincipalinvestigatorStart date: 2024-07-20
NCT06945068Phase 1Not Yet Recruiting
An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Principalinvestigator
NCT07470151Not ApplicableRecruiting
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Myasthenia Gravis (MG)SclerodermaSystem Lupus Erythematosus(SLE)
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT06946199Phase 1PrincipalInvestigator

An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Recruiting
NCT06245746Phase 1PrincipalInvestigator

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Acute Myeloid LeukemiaAnemiaBleeding+3 more
Recruiting
NCT06349343Phase 1PrincipalInvestigator

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Recruiting
NCT06400537Phase 1PrincipalInvestigator

Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Recruiting
NCT05672420Phase 1/2StudyDirector

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

AnemiaBleedingHematologic Neoplasms+3 more
Unknown
NCT06945068Phase 1PrincipalInvestigator

An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)
Not Yet Recruiting
NCT07470151Not ApplicablePrincipalInvestigator

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

Myasthenia Gravis (MG)SclerodermaSystem Lupus Erythematosus(SLE)
Recruiting

All 7 trials loaded